非编码RNA,编程细胞死亡和相关机制之间的多重交叉:在血液性恶性瘤中的一个动态双重组
Mehrdad Hashemi1,2, Niloufar Salimian1,3, Nafiseh Sharifi1,4
1Farhikhtegan Medical Convergent Sciences Research Center, Farhikhtegan Hospital, Faculty of Medicine, TMs. C., Islamic Azad University, Tehran, Iran.
Cancer cell international
|October 15, 2025
概括
非编码RNAs (ncRNAs) 是编程细胞死亡 (PCD) 在白血病等血液癌症中的关键调节者. 了解这种ncRNA-PCD相互作用为血液性恶性瘤提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 血液性恶性瘤 (白血病,淋巴瘤,多发性骨髓瘤) 是血液系统的癌症.
- 非编码RNAs (ncRNAs),包括微RNAs (miRNAs) 和长非编码RNAs,调节基因表达和细胞命运.
- 编程细胞死亡 (PCD) 对于组织平衡和癌症预防至关重要.
研究的目的:
- 探索ncRNAs在调节血性恶性瘤中编程细胞死亡 (PCD) 途径中的作用.
- 研究ncRNAs如何影响这些癌症的瘤发育,进展和耐药性.
- 为针对ncRNA-PCD相互作用的新型治疗策略提供见解.
主要方法:
- 关于ncRNAs,PCD和血液恶性瘤的研究的文献综述.
- 分析PCD途径中ncRNAs的调节机制.
- 检查ncRNA失调对癌症进展和耐药性的影响.
主要成果:
- ncRNAs是白血病,淋巴瘤和多发性髓瘤中PCD途径的关键调节器.
- 对ncRNAs的失调与逃避PCD有关,PCD是癌症的标志.
- 在血液性恶性瘤中,ncRNAs在药物耐药性的发展中发挥着重要作用.
结论:
- 在血液性恶性瘤中,ncRNAs和PCD之间的相互作用至关重要.
- 准ncRNA介导的PCD调制为新型抗瘤疗法提供了一个有希望的途径.
- 对ncRNA功能的进一步研究可以改善血液癌症患者的治疗结果.
相关概念视频
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Overview of Cell Death
9.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K


